-
21.N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors 失效
标题翻译: N-取代的吡唑基 - 氨基 - 苯并咪唑基c-Kit抑制剂公开(公告)号:US20080221187A9
公开(公告)日:2008-09-11
申请号:US10919973
申请日:2004-08-16
申请人: Joshua Bolger , Arlindo Castelhano , Andrew Crew , Radoslaw Laufer , An-Hu Li , Colin Sambrook Smith , Yingchuan Sun
发明人: Joshua Bolger , Arlindo Castelhano , Andrew Crew , Radoslaw Laufer , An-Hu Li , Colin Sambrook Smith , Yingchuan Sun
IPC分类号: A61K31/4184 , C07D403/02
CPC分类号: C07D403/12
摘要: Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of cancer.
摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐或N-氧化物可用于治疗癌症。
-
公开(公告)号:US08445510B2
公开(公告)日:2013-05-21
申请号:US13108024
申请日:2011-05-16
申请人: Mark J. Mulvihill , Arno G. Steinig , Andrew Philip Crew , Meizhong Jin , Andrew Kleinberg , An-Hu Li , Jing Wang
发明人: Mark J. Mulvihill , Arno G. Steinig , Andrew Philip Crew , Meizhong Jin , Andrew Kleinberg , An-Hu Li , Jing Wang
IPC分类号: A61K31/437 , C07D471/04
CPC分类号: C07D471/04
摘要: Compounds of Formula I, as shown below and defined herein: pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by at least one of RON, MET or ALK. This Abstract is not limiting of the invention.
摘要翻译: 式I化合物,如下文所示和定义:其药学上可接受的盐,合成,中间体,制剂及其治疗方法,包括治疗癌症,例如至少部分地通过至少一种RON, MET或ALK。 本发明并不限于本发明。
-
23.
公开(公告)号:US08367826B2
公开(公告)日:2013-02-05
申请号:US13308694
申请日:2011-12-01
申请人: Radoslaw Laufer , An-Hu Li , Mark J. Mulvihill , Arno G. Steinig
发明人: Radoslaw Laufer , An-Hu Li , Mark J. Mulvihill , Arno G. Steinig
IPC分类号: C07D471/00
CPC分类号: C07F5/025 , C07D471/04 , C07D487/04
摘要: Compounds of the formula and pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.
摘要翻译: 其中X 1,X 2,X 3,X 4,X 5,X 6,X 7,R 1和Q 1在本文中定义的式及其药学上可接受的盐的化合物抑制IGF-1R酶,并且可用于治疗和/或预防 过度增生性疾病如癌症,炎症,牛皮癣,过敏/哮喘,免疫系统的疾病和状况,中枢神经系统的疾病和状况。
-
公开(公告)号:US07696225B2
公开(公告)日:2010-04-13
申请号:US10973870
申请日:2004-10-26
申请人: Jason Bloxham , Andrew Phillip Crew , Ayako Honda , An-Hu Li , Bijoy Panicker , Graham Michael Wynne , Lawrence Tardibono, Jr.
发明人: Jason Bloxham , Andrew Phillip Crew , Ayako Honda , An-Hu Li , Bijoy Panicker , Graham Michael Wynne , Lawrence Tardibono, Jr.
IPC分类号: A61K31/4745 , A61K31/4709 , A61K31/4436
CPC分类号: A61K31/381 , A61K31/437 , A61K31/4436 , A61K31/4709 , A61K31/4745 , A61K45/06 , C07D409/12 , C07D409/14 , C07D471/04 , A61K2300/00
摘要: Amidoaryl/amidoheteroaryl substituted thiophenes, further substituted with a heteroarylmethylamino group, are useful in the treatment of cancer.
摘要翻译: 进一步被杂芳基甲基氨基取代的酰胺芳基/酰胺基芳基取代的噻吩可用于治疗癌症。
-
公开(公告)号:US20050154014A1
公开(公告)日:2005-07-14
申请号:US10973870
申请日:2004-10-26
申请人: Jason Bloxham , Andrew Crew , Ayako Honda , An-Hu Li , Bijoy Panicker , Lawrence Tardibono , Graham Wynne
发明人: Jason Bloxham , Andrew Crew , Ayako Honda , An-Hu Li , Bijoy Panicker , Lawrence Tardibono , Graham Wynne
IPC分类号: A61K31/381 , A61K31/437 , A61K31/4436 , A61K31/4709 , A61K31/4745 , A61K45/06 , C07D409/12 , C07D409/14 , C07D471/04 , C07D49/02
CPC分类号: A61K31/381 , A61K31/437 , A61K31/4436 , A61K31/4709 , A61K31/4745 , A61K45/06 , C07D409/12 , C07D409/14 , C07D471/04 , A61K2300/00
摘要: Amidoaryl/amidoheteroaryl substituted thiophenes, further substituted with a heteroarylmethylamino group, are useful in the treatment of cancer.
摘要翻译: 进一步被杂芳基甲基氨基取代的酰胺芳基/酰胺基芳基取代的噻吩可用于治疗癌症。
-
公开(公告)号:US20060035921A1
公开(公告)日:2006-02-16
申请号:US10921418
申请日:2004-08-16
申请人: Arlindo Castelhano , Andrew Crew , Han-Qing Dong , Radoslaw Laufer , An-Hu Li , Li Qiu , Colin Sambrook Smith , Tao Zhang
发明人: Arlindo Castelhano , Andrew Crew , Han-Qing Dong , Radoslaw Laufer , An-Hu Li , Li Qiu , Colin Sambrook Smith , Tao Zhang
IPC分类号: C07D471/02 , A61K31/4745
CPC分类号: C07D471/04
摘要: Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of cancer.
摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐或N-氧化物可用于治疗癌症。
-
公开(公告)号:US07767673B2
公开(公告)日:2010-08-03
申请号:US12209862
申请日:2008-09-12
申请人: Arlindo L. Castelhano , Andrew P. Crew , Han-Qing Dong , Radoslaw Laufer , An-Hu Li , Li Qiu , Colin Peter Sambrook Smith , Tao Zhang
发明人: Arlindo L. Castelhano , Andrew P. Crew , Han-Qing Dong , Radoslaw Laufer , An-Hu Li , Li Qiu , Colin Peter Sambrook Smith , Tao Zhang
IPC分类号: A61K31/5377 , C07D413/12
CPC分类号: C07D471/04
摘要: Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-Oxide thereof, are useful in the treatment of cancer.
摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐或N-氧化物可用于治疗癌症。
-
公开(公告)号:US20090062275A1
公开(公告)日:2009-03-05
申请号:US12209862
申请日:2008-09-12
申请人: Arlindo L. Castelhano , Andrew Phillip Crew , Han-Qing Dong , Radoslaw Laufer , An-Hu Li , Li Qiu , Colin Peter Sambrook Smith , Tao Zhang
发明人: Arlindo L. Castelhano , Andrew Phillip Crew , Han-Qing Dong , Radoslaw Laufer , An-Hu Li , Li Qiu , Colin Peter Sambrook Smith , Tao Zhang
IPC分类号: A61K31/5377 , C07D471/04 , A61K31/437
CPC分类号: C07D471/04
摘要: Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of cancer.
摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐或N-氧化物可用于治疗癌症。
-
公开(公告)号:US07442709B2
公开(公告)日:2008-10-28
申请号:US10921418
申请日:2004-08-16
申请人: Arlindo L. Castelhano , Andrew Phillip Crew , Han-Qing Dong , Radoslaw Laufer , An-Hu Li , Li Qiu , Colin Peter Sambrook Smith , Tao Zhang
发明人: Arlindo L. Castelhano , Andrew Phillip Crew , Han-Qing Dong , Radoslaw Laufer , An-Hu Li , Li Qiu , Colin Peter Sambrook Smith , Tao Zhang
IPC分类号: A61K31/44 , C07D471/02 , C07D491/02
CPC分类号: C07D471/04
摘要: Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of cancer.
摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐或N-氧化物可用于治疗癌症。
-
公开(公告)号:US20080221153A9
公开(公告)日:2008-09-11
申请号:US10921418
申请日:2004-08-16
申请人: Arlindo Castelhano , Andrew Crew , Han-Qing Dong , Radoslaw Laufer , An-Hu Li , Li Qiu , Colin Sambrook Smith , Tao Zhang
发明人: Arlindo Castelhano , Andrew Crew , Han-Qing Dong , Radoslaw Laufer , An-Hu Li , Li Qiu , Colin Sambrook Smith , Tao Zhang
IPC分类号: C07D471/02 , A61K31/4745
CPC分类号: C07D471/04
摘要: Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of cancer.
摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐或N-氧化物可用于治疗癌症。
-
-
-
-
-
-
-
-
-